ID Database Citation 3798106 Pubmed "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Science. 1987 Jan 9;235(4785):177–82. PubMed Europe PMC Scholia" 15805248 Pubmed "PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, et al. Cancer Res. 2005 Apr 1;65(7):2554–9. PubMed Europe PMC Scholia" 17397528 Pubmed "FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Elbauomy Elsheikh S, Green AR, Lambros MBK, Turner NC, Grainge MJ, Powe D, et al. Breast Cancer Res. 2007;9(2):R23. PubMed Europe PMC Scholia" 18676830 Pubmed "An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, et al. Cancer Res. 2008 Aug 1;68(15):6084–91. PubMed Europe PMC Scholia" 20453058 Pubmed "Predictive biomarkers of sensitivity to the phosphatidylinositol 3’ kinase inhibitor GDC-0941 in breast cancer preclinical models. O’Brien C, Wallin JJ, Sampath D, GuhaThakurta D, Savage H, Punnoose EA, et al. Clin Cancer Res. 2010 Jul 15;16(14):3670–83. PubMed Europe PMC Scholia" 20570901 Pubmed "Potential for targeting the fibroblast growth factor receptors in breast cancer. Hynes NE, Dey JH. Cancer Res. 2010 Jul 1;70(13):5199–202. PubMed Europe PMC Scholia" 23220880 Pubmed "Activating HER2 mutations in HER2 gene amplification negative breast cancer. Bose R, Kavuri SM, Searleman AC, Shen W, Shen D, Koboldt DC, et al. Cancer Discov. 2013 Feb;3(2):224–37. PubMed Europe PMC Scholia" 25514926 Pubmed "PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20. PubMed Europe PMC Scholia" 26028978 Pubmed "PI3K mutations in breast cancer: prognostic and therapeutic implications. Mukohara T. Breast Cancer (Dove Med Press). 2015 May 15;7:111–23. PubMed Europe PMC Scholia" 27251275 Pubmed "Proteogenomics connects somatic mutations to signalling in breast cancer. Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. Nature. 2016 Jun 2;534(7605):55–62. PubMed Europe PMC Scholia" 28348404 Pubmed "Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, et al. Nat Commun. 2017 Mar 28;8:14864. PubMed Europe PMC Scholia"